FUT9 and malignant colon neoplasm: To test the prediction that FUT9 downregulation supports colon cancer aggressiveness, we silenced its expression using shRNA‐based knockdowns in two colorectal cancer cell lines, HCT116 and DLD1 that express FUT9 (Fig 3C).